L-arginine and cardiovascular system

Pharmacological Reports

Volumn 57, Issue 1, 2005, Pages 14-22

  Cylwik, Dorota ^a   Mogielnicki, Andrzej ^a   Buczko, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cardiovascular system; Hemostasis; L arginine

Indexed keywords

AMINO ACID; AMMONIA; ANTIHYPERTENSIVE AGENT; ARGININE; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLOBULIN; NITRIC OXIDE; ORNITHINE; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN PRECURSOR; UREA;

ANGINA PECTORIS; ANTICOAGULATION; ATHEROMA; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR SYSTEM; CIGARETTE SMOKING; CONGESTIVE HEART FAILURE; DETOXIFICATION; DIABETES MELLITUS; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VITRO STUDY; MOUSE; NONHUMAN; PREECLAMPSIA; RABBIT; RAT; REVIEW; SCIENTIFIC LITERATURE; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; THROMBOCYTE AGGREGATION INHIBITION; UREA CYCLE; VASCULAR ENDOTHELIUM; VASODILATATION; VIRUS MYOCARDITIS; VOLUNTEER;

EID: 18044377751     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Abdelhamed AI, Reis SE, Sane DC, Brosnihan KB, Preli RB, Herrington DM: No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia. Am Heart J, 2003, 145, E15.
2. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajet DS: Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coil Cardiol, 1995, 26, 1054-1061.
3. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS: Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis, 1997, 129, 261-269.
4. Aji W, Ravalli S, Szabolcs M, Jiang X, Sciacca RR, Michler RE, Cannon PJ: L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation, 1997, 95, 430-437.
5. Alexander BT, Llinas MT, Kruckeberg WC, Granger JP: L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension, 2004, 43, 832-836.
6. Berkenhoom G, Crasset V, Unger P, Vachiery JL, LeClerc JL: Absence of L-arginine effect on coronary hypersensitivity to serotonin in cardiac transplant recipients. Am J Cardiol, 1999, 84, 1182-1186.
7. Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA et al.: Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopansal women. J Am Coll Cardiol, 2000, 35, 271-276.
8. Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waclawiw MA et al.: Oral L-arginine in patients with coronary artery disease on medical management. Circulation, 2000, 101, 2160-2164.
9. Blum A, Porat R, Rosenschein U, Keren G, Roth A, Laniado S, Miller H: Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris. Am J Cardiol, 1999, 83, 1488-1490.
10. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K et al.: L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation, 1996, 93, 85-90.
11. Bode-Böger SM, Böger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, Frölich JC: L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci, 1994, 87, 303-310.
12. Bode-Böger SM, Böger RH, Kienke S, Bohme M, Phivthong-ngam L, Tsikas D, Frölich JC: Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. Cardiovasc Res, 1998, 37, 756-764.
13. Boegehold MA: Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats. Hypertension, 1992, 19, 290-295.
14. Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Bohme M, Nafe R, Mugge A et al.: Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits. Comparison with lovastatin. Circulation, 1997, 96, 1282-1290
15. Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC: Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis, 1995, 117, 273-284.
16. Böger RH, Bode-Böger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mugge A, Bohme M et al.: Dietary L-arginine and alfa-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis, 1998, 141, 31-43.
17. Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC: Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent clandication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol, 1998, 32, 1336-1344.
18. Briones AM, Alonso MJ, Hernanz R, Miguel M, Salaices M: Alterations of nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats. J Cardiovasc Pharmacol, 2002, 39, 378-388.
19. Ceremuzyński L, Chamiec T, Herbaczyńska-Cedro K: Effect of supplemental oral 1-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol, 1997, 80, 331-333.
20. Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL: Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler Thromb Vasc Biol, 2003, 23, 97-103.
21. Chin-Dusting JP, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL: Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol, 1996, 27, 1207-1213.
22. Chin-Dusting JPF, Alexander CT, Arnold PJ, Hodgson WC, Lus AS, Jennings GLR: Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J Cardiovasc Pharmacol, 1996, 28, 158-166.
23. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN et al.: Oral L-arginine improves endothelium-dependent dilation of hypercholesterolemic young adults. J Clin Invest, 1996, 97, 1989-1994.
24. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest, 1992, 90, 1168-1172.
25. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzan VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest, 1992, 90, 1248-1253.
26. Davies MG, Barber E, Dalen H, Hagen PO: L-arginine supplementation improves venous endothelial cell but not smooth muscle cell dysfunction induced by prolonged diet-induced hypereholesterolemia. J Invest Surg, 1996, 6, 415-422,
27. Davies MG, Dalen H, Kim JH, Barber L, Svendsen E, Hagen PO: Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine. J Surg Res, 1995, 59, 35-42.
28. Davies MG, Fulton GJ, Huynh TT, Barber L, Svendsen E, Hagen PO: Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma. Ann Vasc Surg, 1999, 13, 484-493.
29. Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE: L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes. Diabetes Care, 2003, 26, 1836-1840.
30. Dewanjee MK, Wu SM, Kapadvanjwala M, De D, Dewanjee S, Novak S, Hsu LC et al.: Reduction of platelet thrombi and emboli by L-arginine during cardiopulmonary bypass in a pig model. J Thromb Thrombolysis, 1996, 3, 343-360.
31. Facchinetti F, Neri I, Piccinini F, Marietta M, Torelli U, Broschettini PL, Volpe A: Effect of L-arginine load on platelet aggregation: a comparison between normotensive and preeclamptic pregnant women. Acta Obstet Gynecol Scand, 1999, 78, 515-519.
32. Gellman J, Hare JM, Lowenstein CJ, Gerstenblith G, Coombs V, Langenberg P, Brinker JA et al.: L-arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature. Angiology, 2004, 55, 1-8.
33. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F et al.: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation, 1997, 95, 1783-1790.
34. Giugliano D, Marfella R, Verrazzo G, Acampora R, Nappo F, Ziccardi P, Coppola L et al.: L-arginine for testing endothelium-dependent vascular functions in health and disease. Am J Physiol, 1997, 273, E606-E612.
35. Gouvea SA, Moyses MR, Bissoli NS, Pires JG, Cahral AM, Ahreu GR: Oral administration of L-arginine decreases blood pressure and increases renal excretion of sodium and water in renovascular hypertensive rats. Braz J Med Biol Res, 2003, 36, 943-949.
36. Gryglewski R.I, Grodzińiska L, Kostka-Trabka E, Korbut R, Bieroń K, Goszcz A, Stawifiski M: Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease. Wien Klin Wochenschr, 1996, 108, 111-116.
37. Guzik TJ, West NE, Pillai R, Taggart DP, Chaunon KM: Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension, 2002, 39, 1088-1098.
38. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G: Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol, 2000, 35, 706-713.
39. Hamon M, Vallet B, Bauters Ch, Wernert N, McFadden E, Lablanche J-M, Dupuis B et al.: Long term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation, 1994, 90, 1357-1362.
40. Hiraoka Y, Kishimoto Ch, Takada H, Ochiai H: Oral administration of L-arginine prevents congestive heart failure in murine viral myocarditis. J Cardiovasc Pharmacol, 2002, 40, 1-8.
41. Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T: L-arginine as an antihypertensive agent. J Cardiovasc Pharmacol, 1992, 20, Suppl 12, S196-S197.
42. Hutchison SDJ, Sievers RE, Zhn BQ, Sun YP, Stewart DJ, Parmley WW, Chatterjee K: Secondhand tobacco smoke impairs rabbit pulmonary artery endothelium-dependent relaxation. Chest, 2001, 120, 2004-2012.
43. Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu B-Q, Sun Y-P, Chou TM et al.: Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension, 1997, 29, 1186-1191.
44. Hutchison SJ, Sidhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Chatterjee K et al.: Effects of L-arginine on atherogenesis and endothelial dysfunction due to second-hand smoke. Hypertension, 1999, 34, 44-50.
45. Jeremy RW, McCarron H, Sullivan D: Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in hypercholesterolemic rabbit. Circulation, 1996, 94, 498-506.
46. Kawabata A, Hata T: Attenuation by prolonged nitric oxide synthase inhibition of the enhancement of fibrinolysis caused by environmental stress in the rat. Br J Pharmacol, 1996, 119, 346-350.
47. Lerman A, Burnett JC, Higano ST, McKinley LJ, Holmes DR: Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation, 1998, 97, 2123-2128.
48. Le Tournean T, Van Belle E, Corseanx D, Vallet B, Lebuffe G, Dupuis B, Lablanche JM et al.: Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling. J Am Coll Cardiol, 1999, 33, 876-882.
49. Marietta M, Facchinetti F, Neri I, Piccinini F, Volpe A, Torelli G: L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release. Thromb Res, 1997, 88, 229-235.
50. Maxwell AJ, Zapien MP, Pearce GL, MacCallum G, Stone PH: Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol, 2002, 39, 37-45.
51. Mendez JD, Zarzoza E: Inhibition of platelet aggregation by L-arginine and polyamines in alloxan-treated rats. Biochem Mol Biol Int, 1997, 43, 311-318.
52. Mimran A, Ribstein J, DuCailar G: Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension, 1995, 26, 937-941.
53. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med, 1993, 27, 2002-2012.
54. Neri I, Marietta M, Piccinini F, Volpe A, Facchinetti F: The L-argining-nitric oxide system regulates platelet aggregation in pregnancy. J Soc Gynecol Investig, 1998, 5, 192-196.
55. Neri I, Piccinini F, Marietta M, Facchinetti F, Volpe A: Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertens Pregnancy, 2000, 19, 323-330.
56. Oomen CM, van Erk MJ, Feskens EJ, Kok FJ, Kromhout D: Arginine intake and risk of coronary heart disease mortality in elderly men. Arterioscler Thromb Vasc Biol, 2000, 20, 2134-2139.
57. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987, 327, 524-526.
58. Panza JA, Casino PIL Badar DM, Quyyumi AA: Effect of increased availability of endothelinm-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation, 1993, 87, 1475-1481.
59. Piatti PM, Fragaso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R et al.: Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms. Circulation, 2003, 107, 429-436.
60. Piatti PM., Monti LD, Valsecchi G, Magui F, Setola E, Marchesi F, Galli-Kienle M et al.: Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care, 2001, 24, 875-880.
61. Preli RB, Klein KP, Herrington DM: Vascular effects of dietary L-arginine supplementation. Atherosclerosis, 2002, 162, 1-15.
62. Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH: Randomized, double-blind, placebo controlled study of supplemental oral L-arginine in patients with heart failure. Circulation, 1996, 93, 2135-2141.
63. Schini VB, Vanhoutte PM: L-arginine evokes relaxations of the rat aorta in both the presence and absence of endothelial cells. J Cardiovasc Pharmacol, 1991, 17, Suppl 3, S10-S14.
64. Siani A, Pagano E, Iacoviello L, Scopacasa F, Strazullo P: Blood preassure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens, 2000, 13, 547-551.
65. Singer AH, Tsao PS, Wang BY, Bloch DA, Cooke JP: Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits. J Cardiovasc Pharmacol, 1995, 25, 710-716.
66. Sozykin AV, Noeva EA, Balakhonova TV, Pogorelova OA, Men'shikov MI: Effect of L-arginine on platelet aggregation, endothelial function and exercise tolerance in patients with stable angina pectoris. Ter Arkh, 2000, 72, 24-27.
67. Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T: Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand, 2004, 83, 103-107.
68. Stief TW, Weippert M, Kretschmer V, Renz H: Arginine inhibits hemostasis activation. Thromb Res, 2001, 104, 265-274.
69. Sun BL, Zhang SM, Xia ZL, Yang MF, Yuan H, Zhang J, Xiu RJ: L-arginine improves cerebral blood perfusion and vasomotion of microvessels following subarachnoid hemorrhage in rats. Clin Hemorheol Micricirc, 2003, 29, 391-400.
70. Sun YP, Zhu B-Q, Browne AEM, Gao I-R, Chou TM, Chatterjee K, Sudhir K et al.: L-arginine decreases blood pressure and left ventricular hyperthrophy in rats with experimental aortic coarctation. J Am Coll Cardiol, 1998, 31, Suppl A, 501A
71. Tarry WC, Makhoul RG: L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty. Arterioscler Thromb, 1994, 14, 938-943.
72. Thomas G, Farhat MY, Ramwell PW: Effect of L-arginine and substituted arginine compouds on platelet aggregation: role of endothelium. Thromb Res, 1990, 60, 425-429.
73. Tousoulis D, Davies GJ, Tentolouris C, Crake T, Goumas G, Stefanadis C, Toutouzas P: Effects of L-arginine on flow-mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries. Heart, 2003, 89, 531-534.
74. Tsao PS, Theilmeier G, Singer AH, Leung LLK, Cooke JP: L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb, 1994, 14, 1529-1533.
75. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP: Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol, 1996, 28, 1573-1579.
76. Wang BY, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP: Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol, 1994, 23, 452-458.
77. Wang YY, Wang JY, Fu YL, Wang C, Peng SQ: Inhibition of platelet function by L-arginine L-aspartate salt. Sheng Li Xue Bao, 2001, 53,303-306.
78. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, Tsao PS et al.: Dietary L-arginine supplemenration normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol, 1997, 29, 479-485.
79. Zimmermann C, Wimmer M, Haberl RL: L-arginine-mediated vasoreactivity in patients with a risk of stroke. Cerebrovasc Dis, 2004, 17, 128-133.